MedTrace Installs P3 System at Sahlgrenska University Hospital
MedTrace Installs P3 System at Sahlgrenska University Hospital MedTrace Pharma A/S has signed a contract with Sahlgrenska University Hospital in Gothenburg, Sweden for the installation of a new P3 production and infusion system providing up to 1000 doses of 15O-water per year for the next five years. The Gothenburg-based hospital, one of the largest in […]
Investors inject $30 million into Danish medical imaging company
Investors inject $30 million into Danish medical imaging company Swiss-based Swisscanto Invest and Danish investors ATP and BankInvest are the main investors injecting nearly $30 million into MedTrace, a company specialized in diagnosis of heart diseases. The fresh capital is a significant step forward in the company’s plan to expand into the USA as well […]
First patient imaged with MedTrace technology
First patient imaged with MedTrace technology The first PET scans with 15O-water generated with a novel production and administration system from the Danish company MedTrace Pharma A/S (MedTrace) have been performed in patients at Aarhus University Hospital (AUH). AUH has become the first hospital in the world to utilize, under a magistral exemption, a clinical […]
MedTrace to partner with Mayo Clinic in oncology study
MedTrace to partner with Mayo Clinic in oncology study As part of the recently closed equity fundraising, MedTrace also signed a know-how license agreement with Mayo Clinic (Rochester, MN, USA) embarking on the already installed P3 prototype and the aQuant software. The scope of the agreement is outlined in the press release below. Press Release […]
MedTrace feature article in Børsen
MedTrace feature article in Børsen MedTrace is proud to see a feature article in Børsen (May 26th, 2020), Denmarks leading business newspaper. CEO Martin Stenfeldt was interviewed about the latest progress, the next steps and his view on market launch estimates as well as exit opportunities. The article requires a subscription to Børsen to access […]
MedTrace accomplishes funding of DKK 21M
MedTrace accomplishes funding of DKK 21M MedTrace Pharma A/S has completed a capital raise against equity to advance our preparations for the upcoming clinical trial phase III. Three new investors have injected cash into MedTrace along with current investors and loans have been converted to new share capital. The proceeds extend the company’s runway well […]
Putting the low radiation dose of 15O-water in perspective
Putting the low radiation of 15O-water in perspective Tracers are radioactive compounds that doctors inject into patients to diagnose various diseases by, for example, following the flow of blood or use of sugar in organs. All tracers come with a radiation dose, but the dose of 15O-water is much lower than all other tracers used […]
Manufacturing Partnership
Manufacturing Partnership with A/S Kurt Hansen In preparation for our future production of hardware systems, we have partnered with A/S Kurt Hansen from Svendborg, Denmark to manufacture the next five P3 prototype systems. Planned delivery for the first system is first week of December whereas the last unit is planned to be delivered in early […]
ASNC Young Investigator’s Award
Hans receives the Young Investigator’s Award at ASNC Hans Harms, our VP of Software Development, received the Young Investigator’s Award at the ASNC meeting this year. The distinguished prize was awarded for his presentation of the study “Elevated Right-Ventricular Blood Flow is Associated with Diastolic Dysfunction and Adverse Cardiovascular Events, Including Heart Failure with Preserved […]
Japanese Country Manager
Japanese Country Manager on board Since the beginning of our activities in Japan, we have had the pleasure of working together with Yumi Murakami from the Danish Embassy in Tokyo. She has since left the embassy and we have been able to engage her part-time to function as Country Manager for our Japanese activities. Her […]